Iovance Biotherapeutics (IOVA)
(Delayed Data from NSDQ)
$9.66 USD
-0.49 (-4.83%)
Updated Sep 23, 2024 04:00 PM ET
After-Market: $9.70 +0.04 (0.41%) 5:14 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/5/24 |
---|---|
Current Quarter | -0.31 |
EPS Last Quarter | -0.34 |
Last EPS Surprise | 8.11% |
ABR | 1.29 |
Earnings ESP
|
-9.09% |
---|---|
Current Year | -1.27 |
Next Year | -0.79 |
EPS (TTM) | -1.67 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 53.45M | 76.47M | 161.70M | 454.44M |
# of Estimates | 6 | 6 | 7 | 7 |
High Estimate | 54.21M | 79.00M | 164.30M | 474.00M |
Low Estimate | 53.00M | 74.75M | 158.93M | 437.83M |
Year ago Sales | 0.47M | 0.48M | 1.19M | 161.70M |
Year over Year Growth Est. | 11,271.49% | 15,831.88% | 13,499.50% | 181.04% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.31 | -0.31 | -1.27 | -0.79 |
# of Estimates | 6 | 5 | 8 | 7 |
Most Recent Consensus | -0.34 | -0.33 | -1.43 | -0.82 |
High Estimate | -0.25 | -0.19 | -0.84 | -0.45 |
Low Estimate | -0.35 | -0.41 | -1.52 | -1.17 |
Year ago EPS | -0.46 | -0.45 | -1.89 | -1.27 |
Year over Year Growth Est. | 32.61% | 31.11% | 32.80% | 37.51% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 1 |
Up Last 60 Days | 1 | 1 | 4 | 4 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 1 | 1 | 0 |
Down Last 60 Days | 4 | 4 | 4 | 3 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.31 | -0.31 | -1.27 | -0.79 |
7 Days Ago | -0.31 | -0.31 | -1.27 | -0.79 |
30 Days Ago | -0.33 | -0.33 | -1.26 | -0.80 |
60 Days Ago | -0.31 | -0.26 | -1.35 | -0.86 |
90 Days Ago | -0.31 | -0.26 | -1.34 | -0.84 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.34 | -0.33 | -1.43 | -0.82 |
Zacks Consensus Estimate | -0.31 | -0.31 | -1.27 | -0.79 |
Earnings ESP | -9.09% | -5.10% | -13.04% | -3.99% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.34 | -0.42 | -0.45 | -0.46 | NA |
Estimate | -0.37 | -0.45 | -0.44 | -0.46 | NA |
Difference | 0.03 | 0.03 | -0.01 | 0.00 | 0.01 |
Surprise | 8.11% | 6.67% | -2.27% | 0.00% | 3.13% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more